Dr Olalekan Lee Aiyegbusi MBChB, PhD

• Doctor of Philosophy (PhD), University of Birmingham, 2019 
• Masters in Public Health (MPH), University of Birmingham, 2014
• Masters in Business Administration (MBA), University of Cardiff, 2009
• Medicine (MBChB), Obafemi Awolowo University, Nigeria, 2007

Lee qualified with an MBChB in Medicine and Surgery in 2007 and during his internship developed an interest in management and administration. Upon completion of his internship, he studied Business Administration at Cardiff University and worked briefly as a manager in the private sector before enrolling for the part-time master in public health programme at the University of Birmingham which he completed in 2014. 

In 2015, he was awarded the Health Foundation PhD Award in Improvement Science at the University of Birmingham and completed his PhD project in 2018. So far, he has published 7 peer-reviewed articles from his PhD project in reputable journals including the American Journal of Kidney Diseases and Quality of Life Research.

In 2017, Lee was awarded the Westmere Scholarship and served as the Westmere Scholar representing the College of Medical and Dental Sciences. Along with other CPROR members, in 2018, he won the Team Award for Excellence in Patient Public Involvement at the PROMs Conference.

He was appointed as one of the Deputy Directors at CPROR in 2019. CPROR aims to optimize the use of PROs in clinical trials and routine care, to improve service delivery, enhance patient care and outcomes and ensure that the patient perspective is at the heart of health research and NHS decision-making.

Lee is actively involved in teaching, delivering lectures and contributing as co-module lead for the MSc Clinical Trials.

He also takes small group tutorials for the MBChB programme.

PhD supervision

Best practice for implementation of PROs in real world evidence generation. PhD funding.GlaxoSmithKline (GSK). 1 Oct 2020 - 30 Sep 2024

Current Research

• Primary research interests are focused on the management of chronic conditions (including chronic kidney disease); the optimisation of patient-reported outcome assessment in clinical trials and routine clinical practice; patient information and patient public involvement and engagement (PPIE) in research. 

Previous research

• Lee led the development of a PRO template for clinical trials with Professor Mel Calvert working with international expert groups (SPIRIT-PRO group and Industry Advisory Group)
• Lee's PhD research focused on the use of Patient-Reported Outcome Measures (PROMs) to promote quality of care and safety in the management of patients with advanced chronic kidney disease in routine clinical practice.

Research grants

Total current grant income in excess of £3.3 million.  

• Bottomley A, Calvert M, Aiyegbusi OL, Cruz-Rivera S et al. Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials (SISAQOL-IMI) collaborative grant. European Commission Default Scheme. European Commission. 1 Oct 2020 - 30 Sep 2024
• Calvert M, Aiyegbusi OL, Keeley T. Best practice for implementation of PROs in real world evidence generation. PhD funding. GlaxoSmithKline (GSK). 1 Oct 2020 - 30 Sep 2024

• Wootton D, Young B, Aiyegbusi OL, Bradley P. The development of the CoV-Sym questionnaire: a psychometrically validated patient reported outcome measure for use in COVID-19 intervention trials. University of Liverpool Open Call COVID-19 Strategic Funding. 12 months.
• Byrne A, Torrens-Burton A, Grant R, Nelson A, Bulbeck H, Adams R, Calvert M, Watts C, Aiyegbusi OL, Retzer A, Kearns P, Cruz Rivera S, Seddon K, Sivell S. Patient Reported Core Outcomes in Brain Tumour Trials: the COBra study. The Brian Tumor Charity. Research grant. Ref: GN-000704.
• Calvert M, King M, Chan A, Kyte D, Price G, Slade A, Mercieca-Bebber R, Aiyegbusi OL, Cruz Rivera S, Retzer A. Tools to support the uptake and use of SPIRIT-PRO guidance. UCB Biopharma Sprl grant. June 2019 – December 2020.
• Kyte D, Calvert M, Cockwell P, Ferguson J, Horton M, Slade A, Paap M, Aiyegbusi OL, Bissell A. Development of a novel item bank and multidimensional computerized adaptive test (MCAT) to measure patient-reported outcomes and improve management of kidney diseases. Kidney Research UK, Research for Patient Benefit. April 2019 – December 2020.
• Aiyegbusi OL. The Wellcome Trust Institutional Strategic Support Fund (ISSF) via the University of Birmingham Public Engagement Scheme. September 2018.
• Calvert M, Kyte D, Aiyegbusi OL, Denniston A. Industry visit to ERIKs European Technology Centre, Rotterdam. Medical Research Council (MRC) Proximity to Discovery Rapid Response Mobility Fund. January 2018.
• Research groups and centres:
  Centre for Patient-Reported Outcome Research (CPROR)

• Co-Lead for the PRO theme, MRC-NIHR Trial Methodology Research Partnership (TMRP) Outcomes working group (Current).
• Editorial board member, The Patient - Patient Centered Outcomes Research (2017 – 2019)
• MDS Westmere Scholar (2017 – 2018)